Civil Society Involvement in Drug Policy
The objective of the assessment is to gain better insight and create a better understanding of the nature and extent of CSI in regard of drug policy in European Member States.
The assessment of civil society involvement in drug policy is currently being conducted in all Member States of the European Union. This includes a stakeholder and situation analysis, desk research, identification of good practice examples, standardized written interviews and expert interviews.
The assessment will cover the following:
- Definitions and meaning of CSI
- Local, national and European experiences and approaches regarding CSI
- Impact and limitation analysis
- Good practice examples of effective CSI (eg. for initiating new services, for implementing activities, for impact evaluation, etc.)
- Recommendations, which can support the development of the roadmap and the national action plans.
The results are expected in 2017, will provide the basis for the development of a roadmap for CSI in drug policy. The final report is expected at the beginning of 2018 and will be presented at the CSI conference in 2018.
The Annual General Meeting of the Vienna Non-Governmental Organization Committee on Drugs (VNGOC) is scheduled for Thursday, 16.March 2017 from 3.30p.m.- 5.30p.m.read more
The project is funded by the European Commission DG Home drug program for 2 years and coordinated by Correlation Network. Project partners will work on a CSI assessment in the European Union, preparing a roadmap and national action plans in pilot countries. Please...read more
- Ana Liffey also provides the chair of the civil society working group in the current CSF on Drugs.
- Lila provided the co-chair of the Civil society Forum on HIV/AIDS.
- European Civil Society Forum on Drugs
- European Civil Society Forum on HIV/AIDS
- International Drug Policy Consortium
- Harm Reduction International (European Harm Reduction Network),
- European Network of People Who Use Drugs
- European AIDS Treatment Group
Civil Society Involvement in Drug Policy (CSIDP)
c/o Foundation De REGENBOOG GROEP
tel. +31 20 570 7826 (direct)
1013 GE Amsterdam
"This publication has been produced with the financial support of the Migration and Home Affairs Programme of the European Union (Home/2015/JDRU/AG/DRUG/8842). The contents of this publication are the sole responsibility of Correlation and can in no way be taken to reflect the views of the European Commission"